ChemPartner PharmaTech Co Ltd Free Cash Flow Generation Index
ChemPartner PharmaTech Co Ltd free cash flow generation index. ChemPartner PharmaTech Co Ltd (300149) has a Free Cash Flow Generation Index of -1.36x as of June 2023. Free cash flow of CN¥-38.41 Million represents -1% of operating cash flow (CN¥28.21 Million). Check ChemPartner PharmaTech Co Ltd (300149) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of ChemPartner PharmaTech Co Ltd (2007–2025)
Free cash flow generation index of ChemPartner PharmaTech Co Ltd from 2007 to 2025. Historical FCF Generation Index trend for ChemPartner PharmaTech Co Ltd across 19 annual periods. Explore ChemPartner PharmaTech Co Ltd capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
ChemPartner PharmaTech Co Ltd Free Cash Flow Generation Index by Year (2007–2025)
ChemPartner PharmaTech Co Ltd free cash flow generation index by year from 2007 to 2025. Year-by-year Free Cash Flow Generation Index for ChemPartner PharmaTech Co Ltd. For the full cash flow conversion analysis, see ChemPartner PharmaTech Co Ltd cash conversion from operations.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.67x | CN¥128.03 Million | CN¥190.50 Million | CN¥62.47 Million | ▲ +14.2% |
| 2024 | 0.59x | CN¥98.96 Million | CN¥168.21 Million | CN¥69.25 Million | ▲ +276.6% |
| 2023 | -0.33x | CN¥-50.30 Million | CN¥150.99 Million | CN¥201.29 Million | ▼ -18.6% |
| 2022 | -0.28x | CN¥-73.74 Million | CN¥262.46 Million | CN¥336.20 Million | ▼ -215.2% |
| 2021 | 0.24x | CN¥92.22 Million | CN¥378.22 Million | CN¥286.00 Million | ▲ +264.5% |
| 2020 | -0.15x | CN¥-50.87 Million | CN¥343.16 Million | CN¥394.03 Million | ▲ +18.6% |
| 2019 | -0.18x | CN¥-39.16 Million | CN¥215.07 Million | CN¥254.23 Million | ▼ -133.2% |
| 2018 | 0.55x | CN¥133.30 Million | CN¥243.19 Million | CN¥109.88 Million | ▼ -41.3% |
| 2017 | 0.93x | CN¥59.22 Million | CN¥63.43 Million | CN¥4.21 Million | ▼ -18.6% |
| 2016 | 1.15x | CN¥81.71 Million | CN¥71.26 Million | CN¥10.45 Million | ▼ -8.4% |
| 2015 | 1.25x | CN¥126.02 Million | CN¥100.69 Million | CN¥25.33 Million | ▼ -45.3% |
| 2014 | 2.29x | CN¥136.56 Million | CN¥59.63 Million | CN¥76.93 Million | ▼ -3.1% |
| 2013 | 2.36x | CN¥109.50 Million | CN¥46.32 Million | CN¥63.17 Million | ▼ -27.7% |
| 2012 | 3.27x | CN¥180.00 Million | CN¥55.09 Million | CN¥124.91 Million | ▲ +16.4% |
| 2011 | 2.81x | CN¥32.73 Million | CN¥11.66 Million | CN¥21.06 Million | ▲ +54.9% |
| 2010 | 1.81x | CN¥37.70 Million | CN¥20.81 Million | CN¥16.89 Million | ▼ -25.1% |
| 2009 | 2.42x | CN¥32.11 Million | CN¥13.28 Million | CN¥18.83 Million | ▲ +14.0% |
| 2008 | 2.12x | CN¥46.03 Million | CN¥21.70 Million | CN¥24.33 Million | ▲ +64.4% |
| 2007 | 1.29x | CN¥28.64 Million | CN¥22.19 Million | CN¥6.45 Million | — |